CRISPR used to uncover new drug targets for cancer
New potential drug targets have been identified for cancers associated with KRAS gene mutations, which are thought to drive around 20-30 percent of all human cancers...
Rachel Reeves is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She is currently studying for a PhD in Epidemiology at University College London in collaboration with Public Health England. Her research, which is funded by the Farr Institute of Health Informatics Research, focuses on understanding the epidemiology of respiratory syncytial virus in young children in order to inform vaccine policy. Previously, she studied Biology at Newcastle University, where she went on to obtain an MRes in Epidemiology.
New potential drug targets have been identified for cancers associated with KRAS gene mutations, which are thought to drive around 20-30 percent of all human cancers...
Cancer stem cells, thought to be the root cause of tumour recurrence, could be eradicated using vitamin C and antibiotics, suggests a new study...
Two plant chemicals used in folk medicines block a key step in fertilisation, and may provide a potential alternative to hormone-based contraceptives...
The movement of sperm can be explained by a relatively simple mathematical formula, according to new research...
Genes linked to attaining higher levels of education are declining...
A newly discovered gene variant seems to reduce an individual's fondness for alcohol, a study has found...
A newly discovered genetic variant in the Samoan population increases obesity risk by 35 percent — the largest effect of any obesity gene...
Dear Baby Mine is a Radio 4 drama based on the true story of Conor, who is diagnosed with azoospermia, and the emotional rollercoaster that ensues...
The first in-human use of the genome-editing technology CRISPR has been approved by a US federal safety board...
A US federal safety board is set to review an application for the first in-human use of CRISPR/Cas9 genome-editing technology to treat cancer...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.